Grifols

Grifols has been working in the fields of transfusion, blood banking, protein therapeutics and laboratory analysis for more than 70 years.  The company produces plasma-derived medicines for the treatment of a number of rare, genetic, chronic and potentially life-threatening conditions.

Grifols also owns the BioMat USA blood donation centers.